Greenberg Traurig advised ALS Limited on the deal. Australian publicly listed company ALS Limited (ALS) announced the acquisition of the Wessling Group, which includes 17 group...
You must be a Standard 1 Year member to access this content.
Greenberg Traurig has advised Gilde Healthcare on the deal. Gilde Healthcare, a European private equity fund specializing in healthcare investments, announced the acquisition of a majority stake...
You must be a Standard 1 Year member to access this content.
Greenberg Traurig advised Gilde Healthcare on the deal. Gilde Healthcare, a specialist healthcare private equity fund, announced its acquisition of EUROPIN Group, which is headquartered in Heidelberg,...
You must be a Standard 1 Year member to access this content.
Greenberg Traurig advised ALS Limited on the deal. ALS Limited (ALS) announced the acquisition of a 49 percent equity investment in Nuvisan Group (Nuvisan). Going forward, Nuvisan...
You must be a Standard 1 Year member to access this content.
Greenberg Traurig advised LivePerson, Inc. on the deal. YPOG advised the shareholders of e-bot7. Nasdaq-listed U.S. company LivePerson, Inc. (Nasdaq: LPSN) announced the acquisition of Munich-based startup...
You must be a Standard 1 Year member to access this content.
Greenberg Traurig, LLP advised Gilde Healthcare on the deal, while Heuking Kühn Lüer Wojtek and bnt Neupert Zamorska & Partnerzy Sp.J advised Acti-Med AG. Gilde Healthcare,...
You must be a Standard 1 Year member to access this content.
